Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release Apr 23 2025

· Issued by Aurobindo Pharma Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-apr-23-2025-2

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated April 23, 2025, titled "Eugia Pharma receives USFDA approval for Dasatinib Tablets".

View Attachment

6ix hasn’t read this filing yet.

Aurobindo Pharma Ltd on 6ix

Earlier from Aurobindo Pharma

Later from Aurobindo Pharma

All Aurobindo Pharma news releases